Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution.
- Name:
Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution.
- Company:
Galen Pharma Ireland Limited
- Active Ingredients:
Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 25/04/19
(Click to Download)Click on this link to Download PDF directly
Galen Pharma Ireland Limited
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 21 November 2019 SmPC
Reasons for updating
- Change to section 8 - Marketing authorisation number(s)
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 25 April 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 25 April 2019 SmPC
Reasons for updating
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 7 March 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 27 February 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 14 February 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
- Addition of manufacturer
Updated on 17 August 2018 SmPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 3 November 2017 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 3 November 2017 SmPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 1 November 2017 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to section 6 - what the product contains
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
Updated on 24 November 2016 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 2 September 2015 SmPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 September 2015 PIL
Reasons for updating
- New PIL for new product